Jazz Pharmaceuticals (JAZZ) Short Interest Ratio & Short Volume → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free JAZZ Stock Alerts $109.46 +2.03 (+1.89%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Jazz Pharmaceuticals Short Interest DataCurrent Short Volume3,700,000 sharesPrevious Short Volume3,260,000 sharesChange Vs. Previous Month+13.50%Dollar Volume Sold Short$410.37 millionShort Interest Ratio / Days to Cover6.0Last Record DateApril 15, 2024Outstanding Shares63,000,000 sharesFloat Size60,260,000 sharesShort Percent of Float6.14%Today's Trading Volume480,574 sharesAverage Trading Volume504,507 sharesToday's Volume Vs. Average95% Short Selling Jazz Pharmaceuticals ? Sign up to receive the latest short interest report for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatJAZZ Short Interest Over TimeJAZZ Days to Cover Over TimeJAZZ Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Jazz Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,700,000 shares $410.37 million +13.5%6.1%6 $110.91 3/31/20243,260,000 shares $392.57 million +17.7%5.4%5.3 $120.42 3/15/20242,770,000 shares $334.89 million +15.9%4.6%4.3 $120.90 2/29/20242,390,000 shares $284.17 million +3.0%4.0%4 $118.90 2/15/20242,320,000 shares $294.22 million +5.0%N/A4 $126.82 1/31/20242,210,000 shares $271.21 million +2.3%N/A3.4 $122.72 Get the Latest News and Ratings for JAZZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,160,000 shares $256.91 million -1.8%N/A3 $118.94 12/31/20232,200,000 shares $270.60 million -0.5%N/A3.1 $123.00 12/15/20232,210,000 shares $268.52 million -9.1%N/A3.1 $121.50 11/30/20232,430,000 shares $287.30 million -5.5%N/A3.6 $118.23 11/15/20232,570,000 shares $322.28 million -6.2%N/A4 $125.40 10/31/20232,740,000 shares $348.03 million +5.0%N/A4.5 $127.02 10/15/20232,610,000 shares $337.00 million -19.9%N/A4.7 $129.12 9/30/20233,260,000 shares $421.97 million -2.4%N/A6.9 $129.44 9/15/20233,340,000 shares $442.52 million +16.8%N/A6.8 $132.49 8/31/20232,860,000 shares $410.01 million +1.1%N/A5.4 $143.36 8/15/20232,830,000 shares $396.17 million -0.4%N/A5 $139.99 7/31/20232,840,000 shares $370.39 million -5.7%N/A5 $130.42 7/15/20233,010,000 shares $381.34 million +0.3%N/A5.3 $126.69 6/30/20233,000,000 shares $371.91 million +11.5%N/A5.4 $123.97 6/15/20232,690,000 shares $346.82 million -13.8%N/A5.1 $128.93 5/31/20233,120,000 shares $399.86 million +5.1%N/A6.3 $128.16 5/15/20232,970,000 shares $400.00 million +19.8%N/A6 $134.68 4/30/20232,480,000 shares $348.37 million +7.4%N/A5 $140.47 4/15/20232,310,000 shares $336.15 million -10.1%N/A4.8 $145.52 3/31/20232,570,000 shares $376.07 million +10.8%N/A5 $146.33 3/15/20232,320,000 shares $312.94 million -4.9%N/A4.4 $134.89 2/28/20232,440,000 shares $342.58 million -1.6%N/A4.2 $140.40 2/15/20232,480,000 shares $370.54 million -3.9%N/A4.6 $149.41 1/31/20232,580,000 shares $404.18 million -1.9%N/A4.6 $156.66 1/15/20232,630,000 shares $411.52 million -2.6%N/A4.8 $156.47 12/30/20222,700,000 shares $430.14 million +21.1%N/A5 $159.31 12/15/20222,230,000 shares $341.10 million +2.8%N/A4 $152.96 11/30/20222,170,000 shares $340.49 million -7.7%N/A4 $156.91 11/15/20222,350,000 shares $348.83 million -1.7%N/A4.5 $148.44 10/31/20222,390,000 shares $343.66 million +6.2%N/A4.7 $143.79 10/15/20222,250,000 shares $299.72 million -14.1%N/A4.3 $133.21 9/30/20222,620,000 shares $349.22 million -4.4%N/A5 $133.29 9/15/20222,740,000 shares $416.97 million -1.4%N/A5.3 $152.18 8/31/20222,780,000 shares $431.51 million No ChangeN/A5.7 $155.22Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. JAZZ Short Interest - Frequently Asked Questions What is Jazz Pharmaceuticals' current short interest? Short interest is the volume of Jazz Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 3,700,000 shares of JAZZ short. 6.14% of Jazz Pharmaceuticals' shares are currently sold short. Learn More on Jazz Pharmaceuticals' current short interest. What is a good short interest ratio for Jazz Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JAZZ shares currently have a short interest ratio of 6.0. Learn More on Jazz Pharmaceuticals's short interest ratio. Which institutional investors are shorting Jazz Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Jazz Pharmaceuticals: Capstone Investment Advisors LLC, Concourse Financial Group Securities Inc., and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Jazz Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.14% of Jazz Pharmaceuticals' floating shares are currently sold short. Is Jazz Pharmaceuticals' short interest increasing or decreasing? Jazz Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 3,700,000 shares, an increase of 13.5% from the previous total of 3,260,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Jazz Pharmaceuticals' float size? Jazz Pharmaceuticals currently has issued a total of 63,000,000 shares. Some of Jazz Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Jazz Pharmaceuticals currently has a public float of 60,260,000 shares. How does Jazz Pharmaceuticals' short interest compare to its competitors? 6.14% of Jazz Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Jazz Pharmaceuticals: Perrigo Company plc (2.88%), Mirati Therapeutics, Inc. (6.26%), Corcept Therapeutics Incorporated (23.68%), Cytokinetics, Incorporated (13.91%), Viking Therapeutics, Inc. (10.12%), Intra-Cellular Therapies, Inc. (3.71%), Elanco Animal Health Incorporated (3.14%), Cerevel Therapeutics Holdings, Inc. (9.10%), Ionis Pharmaceuticals, Inc. (7.12%), Apellis Pharmaceuticals, Inc. (8.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Jazz Pharmaceuticals stock? Short selling JAZZ is an investing strategy that aims to generate trading profit from Jazz Pharmaceuticals as its price is falling. JAZZ shares are trading up $2.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Jazz Pharmaceuticals? A short squeeze for Jazz Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JAZZ, which in turn drives the price of the stock up even further. How often is Jazz Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JAZZ, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PRGO Short Interest Data MRTX Short Interest Data CORT Short Interest Data CYTK Short Interest Data VKTX Short Interest Data ITCI Short Interest Data ELAN Short Interest Data CERE Short Interest Data IONS Short Interest Data APLS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:JAZZ) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry